Episode 5 - CE 1 - Evidence for the Use of Empagliflozin in Heart Failure with Preserved Ejection Fraction
PAWNYCast
English - January 25, 2022 11:00 - 22 minutes - 21 MB - ★★★★★ - 5 ratingsHealth & Fitness Business Careers Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: Episode 4 - Managed Care - Trade Relations
Next Episode: Episode 6 - Medical Cannabis Dispensary
Drs. Vicky Belousova, Alyssa Wozniak, and Gurjot Sandhu discuss the newly published Evidence for the Use of Empagliflozin in Heart Failure with Preserved Ejection Fraction (HFpEF) trial, otherwise known as the Emperor Preserved Trial.
By listening to this episode, pharmacists in all practice settings may be eligible to receive 0.5 contact hours (0.05 CEU) of continuing education credit.
Fees: non-PAWNY members: $15.00, PAWNY members: $10.00
Sign up here:
Connect with us
Email: [email protected] with your feedback and ideas for the podcastSocial Media: check us out on Facebook and InstagramWebsite: pawnyrx.orgSubscribe to our podcast to never miss a new episode and leave a reviewBe sure to like and review us on your favorite podcasting app!